Sage Biologics Private Limited
About Sage Biologics Private Limited
Data last updated:
Sage Biologics Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2015PTC034938. Its GSTIN is 06AAWCS3544A1ZB (Haryana).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Sunil Kumar Shukla and Bhaskar Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 Malviya Nagar, Bhopal, Madhya Pradesh, India – 462003.
As per the financials filed for FY 2025, the company reported a revenue of ₹51,013, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹90,442 (net margin -177.3%) and EBITDA of -₹75,875 (EBITDA margin -148.7%). Revenue has declined at a compounded annual rate (CAGR) of 86% over three years and 75% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sage Biologics Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 Malviya Nagar, Bhopal, Madhya Pradesh, India – 462003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sage Biologics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sage Biologics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sage Biologics Private Limited, buy the company report.
Financials of Sage Biologics Private Limited
FY 2025 filings availableSage Biologics Private Limited reported revenue of ₹51,013 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 75% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹51,013 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹75,875 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹90,442 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -148.7% | ||||
| Net Profit Margin | -177.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sage Biologics Private Limited, buy the company report.
Board of directors of Sage Biologics Private Limited
Sage Biologics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Shukla | Additional Director | 05 Jul 2016 | 10 Years 4 Months | Current |
| Bhaskar Goyal | Additional Director | 05 Jul 2016 | 10 Years 4 Months | Current |
Peer comparison
Sage Biologics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Biologics, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viilbery Healthcare Private Limited | ₹1.41 Cr (FY 2023) | -36.0% | Mumbai, Maharashtra, India | |||
| Humancare Pharma Private Limited | ₹1.41 Cr (FY 2025) | 35.0% | Bihar, India | |||
| Phylax Pharmaceuticals Private Limited | ₹1.41 Cr (FY 2025) | -63.0% | North 24 Parganas, West Bengal, India | |||
| Raksh Life Care Private Limited | ₹1.4 Cr (FY 2025) | 26.0% | Greater Noida, Uttar Pradesh, India | |||
| Sage Biologics Private Limitedthis company | ₹51,013 (FY 2025) | -₹90,442 | -177.3% | -100.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Sage Biologics Private Limited, buy the company report.
Auditor
Sage Biologics Private Limited is audited by MANJU RAKESH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANJU RAKESH & ASSOCIATES | FY 2023 | 003924C |
Shareholding
The shareholding of Sage Biologics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sage Biologics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sage Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sage Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sage Biologics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAWCS3544A1ZB | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sage Biologics Private Limited, buy the company report.
Recent activity
Sage Biologics Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Harikrishn Sharma ceased to be Director on 15 May 2023.
Frequently asked questions
Sage Biologics is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 November 2015 (11+ years old) and is registered under CIN U24230MP2015PTC034938.
Sage Biologics has 2 current directors:
- Sunil Kumar Shukla - Additional Director
- Bhaskar Goyal - Additional Director
The latest financial statements of Sage Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sage Biologics is 06AAWCS3544A1ZB, registered in Haryana.
The CIN (Corporate Identification Number) of Sage Biologics is U24230MP2015PTC034938. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sage Biologics was incorporated on 05 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Sage Biologics by revenue are Viilbery Healthcare Private Limited, Humancare Pharma Private Limited, Phylax Pharmaceuticals Private Limited, Raksh Life Care Private Limited, all in the Pharma industry (Biologics, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Harikrishn Sharma ceased to be Director on 15 May 2023. Manoj Sethia ceased to be Director on 20 Jul 2016. Bhaskar Goyal was appointed as Additional Director on 05 Jul 2016. Sage Biologics has 4 board changes on record in total.
The registered office of Sage Biologics is at 12 Malviya Nagar, Bhopal, Madhya Pradesh, India – 462003.
Sage Biologics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sage Biologics is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
